SCHEMBL23012923

SCHEMBL23012923

CC(=O)Nc1ccc2nc(-c3ccnc(C(=O)N4CCN(C(c5ccccc5)c5nnn(C(F)F)n5)CC4)c3)oc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 1/20 0.47
▸ SENP8 Q96LD8 1/20 0.47
▸ SENP7 Q9BQF6 1/20 0.47
▸ SENP6 Q9GZR1 1/20 0.47
▸ NPC1 O15118 5/20 0.42
▸ RAB9A P51151 5/20 0.42
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ UTRN P46939 1/20 0.37
▸ NPSR1 Q6W5P4 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ NPY2R P49146 1/20 0.36
▸ LMNA P02545 3/20 0.36
▸ MGLL Q99685 2/20 0.36
▸ NR2E1 Q9Y466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23012142 0.94 ALDH1A1 (0.47) CASP3SENP8SENP7SENP6NPC1
SCHEMBL28701711 0.91 SMN1; SMN2 (0.37) CASP3SENP8SENP7SENP6NPC1
SCHEMBL23012857 0.91 CASP3 (0.36) CASP3SENP8SENP7SENP6NPC1
SCHEMBL23012084 0.90 MGLL (0.38) CASP3SENP8SENP7SENP6NPC1
SCHEMBL23012862 0.90 MGLL (0.38) CASP3SENP8SENP7SENP6NPC1
SCHEMBL23033591 0.90 NPSR1 (0.37) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL23012437 0.90 MGLL (0.35) CASP3SENP8SENP7SENP6NPC1
SCHEMBL23012439 0.90 MGLL (0.35) CASP3SENP8SENP7SENP6NPC1
SCHEMBL28698049 0.89 NPY2R (0.35) CASP3SENP8SENP7SENP6NPC1
SCHEMBL23033584 0.88 NPSR1 (0.38) NPC1RAB9AMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269725-B Anti-influenza virus compound, preparation method and application thereof 西藏海思科制药有限公司 2024-09-17 — — CN disclosed
US-20230079045-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-03-16 — — US disclosed
CN-114269725-A Anti-influenza virus compound and preparation method and application thereof 四川海思科制药有限公司 2022-04-01 — — CN disclosed
WO-2021032209-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF 四川海思科制药有限公司 2021-02-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230079045-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF IDE, ACE, SI CASP3 3904/4885SENP8 641/4885SENP7 500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback